| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |